ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,446, issued on July 14, was assigned to Pfizer Inc. (New York).
"Benzodiazepine derivatives useful in treating a respiratory syncytial virus infection" was invented by Matthew Barrett (Stevenage, Great Britain), George Stuart Cockerill (Stevenage, Great Britain), James Good (Stevenage, Great Britain), Craig Alex Avery (Nottingham, Great Britain), Edward James Cochrane (Nottingham, Great Britain), Stefan Paul Jones (Nottingham, Great Britain), Stuart Thomas Onions (Nottingham, Great Britain) and Andrew Joseph Warner (Nottingham, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "Benzodiazepine derivatives of formula (Ie) wherein one R1 and ...